82 related articles for article (PubMed ID: 25524904)
1. Cardiac amyloidosis presenting with paroxysmal atrial fibrillation.
Kabach M; Zaiem F; Alraies MC
QJM; 2015 Oct; 108(10):819-20. PubMed ID: 25524904
[No Abstract] [Full Text] [Related]
2. Atrial pathology in cardiac amyloidosis: evidence from ECG and cardiovascular magnetic resonance.
Leeson CP; Myerson SG; Walls GB; Neubauer S; Ormerod OJ
Eur Heart J; 2006 Jul; 27(14):1670. PubMed ID: 16449244
[No Abstract] [Full Text] [Related]
3. Diagnosis of cardiac amyloidosis by magnetic resonance imaging due to a new mutation in the transthyretin gene.
Damy T; Plante-Bordeneuve V; Valleix S
Arch Cardiovasc Dis; 2012 Nov; 105(11):614-5. PubMed ID: 23177490
[No Abstract] [Full Text] [Related]
4. Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosis.
Hussain AS; Hari P; Brazauskas R; Arce-Lara C; Pasquini M; Hamadani M; D'Souza A
Am J Hematol; 2015 Nov; 90(11):E212-3. PubMed ID: 26284951
[No Abstract] [Full Text] [Related]
5. Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
Yashiro B; Minami Y; Terajima Y; Hagiwara N
J Cardiol; 2014 Jun; 63(6):432-7. PubMed ID: 24280311
[TBL] [Abstract][Full Text] [Related]
6. Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging.
Varedi D; Kovacsovics T; Downs Kelly E; Abraham J; Cowley J; Barrell K; Revelo MP; Stehlik J; Drakos S; Marrouche N; Wilson B; Swanson EA; Fang J; Nativi-Nicolau J
Circ Heart Fail; 2018 Jul; 11(7):e004812. PubMed ID: 29921704
[No Abstract] [Full Text] [Related]
7. An unusual case of biopsy-negative amyloid cardiomyopathy.
George JC; Katrapati P; Fang J
Congest Heart Fail; 2010; 16(1):39-41. PubMed ID: 20078626
[No Abstract] [Full Text] [Related]
8. Treating advanced cardiac damage in light chain amyloidosis: still an unmet need.
Merlini G; Palladini G
Haematologica; 2014 Sep; 99(9):1407-9. PubMed ID: 25176981
[No Abstract] [Full Text] [Related]
9. [Postmortem diagnosis of cardiac amyloidosis in the aged. Anatomoclinical correlation].
Bustos D; Perrenoud JJ; Michel JP; Grab B; McGee W
Arch Mal Coeur Vaiss; 1993 Mar; 86(3):315-9. PubMed ID: 8215766
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular magnetic resonance in cardiac amyloidosis.
Kwong RY; Falk RH
Circulation; 2005 Jan; 111(2):122-4. PubMed ID: 15657385
[No Abstract] [Full Text] [Related]
11. Atrial enhancement by cardiovascular magnetic resonance in cardiac amyloidosis.
Lyne JC; Petryka J; Pennell DJ
Eur Heart J; 2008 Jan; 29(2):212. PubMed ID: 17704093
[No Abstract] [Full Text] [Related]
12. [Immunogenic cardiac amyloidosis. Value of ultrasonography and endomyocardial biopsy].
Depelchin P; Stoupel E; Vandermoten P; Goffin Y; Degre S
Ann Cardiol Angeiol (Paris); 1985 Apr; 34(4):231-5. PubMed ID: 3893304
[TBL] [Abstract][Full Text] [Related]
13. Primary myocardial amyloidosis.
Miller JS
Br J Clin Pract; 1970 Jun; 24(6):260. PubMed ID: 5456746
[No Abstract] [Full Text] [Related]
14. Histological substrate of human atrial fibrillation.
Chimenti C; Russo MA; Carpi A; Frustaci A
Biomed Pharmacother; 2010 Mar; 64(3):177-83. PubMed ID: 20006465
[TBL] [Abstract][Full Text] [Related]
15. CARDIAC AMYLOIDOSIS DIAGNOSED ON MRI.
Lu P; Van Acker H; Waer P
JBR-BTR; 2015; 98(1):48-9. PubMed ID: 26223068
[TBL] [Abstract][Full Text] [Related]
16. [An atypical case of cardiac amyloidosis].
Giannoni A; Aquaro DG; Masi L; Benedetti E; Cecconi N; Passino C; Emdin M
Recenti Prog Med; 2009 May; 100(5):247-52. PubMed ID: 19772215
[TBL] [Abstract][Full Text] [Related]
17. Cardiac amyloidosis: diagnosis using delayed enhancement cardiac magnetic resonance imaging sequences.
Mesquita D; Nobre C; Thomas B; Jalles Tavares N
Rev Port Cardiol; 2013 Nov; 32(11):941-5. PubMed ID: 24238891
[No Abstract] [Full Text] [Related]
18. [Risk stratification in non ischemic cardiomyopathy: a case report--Case 5/2010].
Parade U; Klingel K; Kandolf R; Gawaz M; Schreieck J
Dtsch Med Wochenschr; 2010 Jun; 135(22):1122. PubMed ID: 20514634
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis.
Lehrke S; Steen H; Kristen AV; Merten C; Lossnitzer D; Dengler TJ; Katus HA; Giannitsis E
Amyloid; 2009 Dec; 16(4):187-95. PubMed ID: 19922329
[TBL] [Abstract][Full Text] [Related]
20. [Circumstances and difficulties of the diagnosis of cardiac amyloidosis].
Salvador M; Marco J; Durroux R; Cazard JC; Dardenne P
Coeur Med Interne; 1972; 11(3):509-16. PubMed ID: 4636691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
